FIELD: clinical and experimental medicine. SUBSTANCE: invention relates to selenium-containing phospholipoglycoprotein organoelemental substances including low-molecular protein component, selenium, organic carbohydrates and phospholipids, inorganic ions: calcium, magnesium and aluminium cations and hydrosulfite, hydrophosphate and dihydro-ortho-silicate anions. Invention can be used in clinical practice for treatment of patients with diseases accompanying with disorders of modulating activity of immune system. EFFECT: activated cellular and humoral defense reactions. 5 cl, 6 dwg, 5 ex
Authors
Dates
2001-12-27—Published
2001-01-22—Filed